Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Julian Schulze Zur Wiesch and Samuel Huber.
Julian Schulze Zur Wiesch
Connection Strength
1.118
Samuel Huber
  1. Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 12 06; 73(11):e4020-e4024.
    View in: PubMed
    Score: 0.246
  2. Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19. iScience. 2021 Jul 23; 24(7):102752.
    View in: PubMed
    Score: 0.238
  3. Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020. J Clin Med. 2021 May 24; 10(11).
    View in: PubMed
    Score: 0.237
  4. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73- Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes. Cells. 2020 07 22; 9(8).
    View in: PubMed
    Score: 0.223
  5. Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness. Trop Med Infect Dis. 2021 Mar 26; 6(2).
    View in: PubMed
    Score: 0.059
  6. Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients. Sci Immunol. 2021 02 23; 6(56).
    View in: PubMed
    Score: 0.058
  7. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study. Int J Hyg Environ Health. 2021 03; 232:113671.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.